Although the activation of the RelA-based canonical NF-κB pathway is involved in chemo- and radiotherapy-mediated PD-L1 induction in cancer cells [32, 33], there is no evidence showing that the RelB-based noncanonical pathway contributes to PD-L1 expression in cancers. This evidence concerns the gene NFKB1 and cancer.